MARKET

DCOY

DCOY

DECOY THERAPEUTICS INC
NASDAQ
3.830
-0.100
-2.54%
After Hours: 3.930 +0.1 +2.61% 16:58 08/10 EDT
OPEN
3.930
PREV CLOSE
3.930
HIGH
4.080
LOW
3.820
VOLUME
7.78K
TURNOVER
--
52 WEEK HIGH
106.20
52 WEEK LOW
3.510
MARKET CAP
2.26M
P/E (TTM)
-0.0038
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at DCOY last week (0803-0807)?
Weekly Report · 18h ago
U.S. CDC Says As Of August 6, 2,465 Confirmed Measles Cases Were Reported In U.S. In 2026; There Have Been 38 New Measles Outbreaks Reported In 2026, And 94% Of Confirmed Cases Are Outbreak-Associated
Benzinga · 3d ago
Decoy Therapeutics Announces The Expansion Of Its Intellectual Property Portfolio, Which Now Comprises Seven Patent Families
Benzinga · 08/03 13:05
Decoy Therapeutics Expands Intellectual Property Portfolio Covering Designable Multi-Antivirals and the IMP³ACT™ Platform
PR Newswire · 08/03 13:00
Weekly Report: what happened at DCOY last week (0727-0731)?
Weekly Report · 08/03 09:29
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 07/27 17:06
Decoy Therapeutics’ D-MAV platform shows inhibition of Ebola Zaire virus
TipRanks · 07/27 13:11
Decoy Therapeutics Announces That One Of Its D-MAV Candidates Demonstrates In Vitro Activity Against Wild-Type Ebola Zaire Virus
Benzinga · 07/27 13:04
More
About DCOY
Decoy Therapeutics Inc., formerly Salarius Pharmaceuticals, Inc., is a preclinical-stage biotechnology company that is leveraging machine learning and artificial intelligence (AI) tools alongside high-speed synthesis techniques to design, engineer and manufacture peptide conjugate drug candidates that target serious unmet medical needs. The Company’s initial pipeline is focused on respiratory viruses and GI cancers. In parallel, the Company is advancing discovery programs, including multi-virus decoy candidates designed to address overlapping respiratory threats, and cell-based and organoid-level validation of novel G protein-coupled receptor (GPCR)-targeted drug candidates outside of antivirals.

Webull offers Decoy Therapeutics Inc stock information, including NASDAQ: DCOY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DCOY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DCOY stock methods without spending real money on the virtual paper trading platform.